FIELD: medicine.
SUBSTANCE: invention refers to medicine and pharmacology, and represents the use of a mixture of probiotic lactic acid bacilli and bifidus bacteria in preparing a composition to be introduced in females at least in the third trimester of pregnancy for preventing gestational diabetes wherein the probiotic lactic acid bacilli are Lactobacillus rhamnosus CGMCC 1.3724 and the probiotic bifidus bacteria are Bifidobacterium lactis CNCM 1-3446.
EFFECT: invention provides reducing a risk of developing gestational diabetes and impaired glucose tolerance in pregnant women.
13 cl, 2 ex, 4 tbl, 1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| PROBIOTICS FOR REDUCING RISK OF OBESITY | 2008 |
|
RU2464994C2 |
| COMPOSITION FOR USE IN INCREASING INSULIN SENSITIVITY AND/OR REDUCING INSULIN RESISTANCE | 2012 |
|
RU2604503C2 |
| PROBIOTICS FOR IMPROVING TgA SECRETION IN INFANTS BORN BY CAESAREAN SECTION | 2009 |
|
RU2496505C2 |
| SINBIOTIC FOR IMPROVING INTESTINAL MICROBIOTA | 2008 |
|
RU2456008C2 |
| USE OF LACTIC ACID BACTERIA FOR TREATING OR PREVENTING GESTATIONAL DIABETES MELLITUS | 2017 |
|
RU2769312C2 |
| USING LACTOBACILLUS REUTERI FOR RECOVERING MICROBIOTA AFTER DYSBIOSIS AT EARLY STAGES OF DEVELOPMENT | 2015 |
|
RU2723687C2 |
| APPLICATION OF NUTRITIONAL COMPOSITIONS WITH LOW PROTEIN VOLUME | 2013 |
|
RU2638323C1 |
| COMPOSITION FOR USE IN PROMOTION OF MAGNESIUM ABSORPTION AND/OR MAGNESIUM RETENTION | 2012 |
|
RU2604502C2 |
| BABY MIXTURE CONTAINING PROBIOTICS | 2006 |
|
RU2428886C2 |
| DIARRHOEA RISK REDUCTION | 2008 |
|
RU2491080C2 |
